Plasmagen Biosciences taps into the niche Indian Biopharmaceutical market with the launch of CSL’s Haemocomplettan® P
Haemocomplettan® P will cater to the 1,50,000 cardiac surgeries and over 1,800 liver transplant patients who are at risk of…
Breaking News, English News, Latest Updates, Top Headlines, Real-Time News, Daily News, Trusted News, News Portal, Global News, Unbiased Updates, Comprehensive News,
Haemocomplettan® P will cater to the 1,50,000 cardiac surgeries and over 1,800 liver transplant patients who are at risk of…